Method for estimating ovarian cancer prognosis by TRPC protein subtype combined detection
A technology for ovarian cancer and prognosis, applied in the direction of biological testing, material inspection products, etc., can solve the problem of not fully reflecting the state of tumor cells
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0011] The present invention is achieved like this:
[0012] 1) With the consent of the patient or the patient's family members, collect ovarian cancer tissue samples and clinical history data from different regions and hospitals. Specimens were immunohistochemically stained to mark TRPC1, 3, 4, 5, 6, and 7 subtypes. The expression intensity was observed under a microscope and graded. The obtained grades and clinical indicators, pathological indicators and patient prognosis are used to establish a mathematical model through multiple linear regression models, and related calculation software is produced;
[0013] 2) On this basis, when the specimens of surgical patients are sent to the pathology department for laboratory testing, in addition to routine pathological examinations, immunohistochemical staining of six TRPC subtypes of TRPC1, 3, 4, 5, 6, and 7 (using Specified company antibody, specified concentration and certain operating procedures);
[0014] 3) The stained sec...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com